A gynecologic oncologist reviews the current state of ovarian cancer and identifies areas of need.
A review of the types of testing patients with ovarian cancer should receive and how testing results impact treatment decisions.
Expert commentary on the rationale and strategies for frontline maintenance therapy in patients with ovarian cancer.
Commentary on adverse events seen with PARP inhibitors and strategies to manage them.
Discussion of approaches to individualize dosing of PARP inhibitors.
Insights are shared on what the future holds for advanced ovarian cancer.